Interleukin-17 (IL-17) expression is reduced during acute myocardial infarction: Role on chemokine receptor expression in monocytes and their in vitro chemotaxis towards chemokines

9Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

The roles of immune cells and their soluble products during myocardial infarction (MI) are not completely understood. Here, we observed that the percentages of IL-17, but not IL-22, producing cells are reduced in mice splenocytes after developing MI. To correlate this finding with the functional activity of IL-17, we sought to determine its effect on monocytes. In particular, we presumed that this cytokine might affect the chemotaxis of monocytes important for cardiac inflammation and remodeling. We observed that IL-17 tends to reduce the expression of two major chemokine receptors involved in monocyte chemotaxis, namely CCR2 and CXCR4. Further analysis showed that monocytes pretreated with IL-17 have reduced in vitro chemotaxis towards the ligand for CCR2, i.e., MCP-1/CCL2, and the ligand for CXCR4, i.e., SDF-1α/CXCL12. Our results support the possibility that IL-17 may be beneficial in MI, and this could be due to its ability to inhibit the migration of monocytes. © 2012 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

Troitskaya, M., Baysa, A., Vaage, J., Sand, K. L., Maghazachi, A. A., & Valen, G. (2012). Interleukin-17 (IL-17) expression is reduced during acute myocardial infarction: Role on chemokine receptor expression in monocytes and their in vitro chemotaxis towards chemokines. Toxins, 4(12), 1427–1439. https://doi.org/10.3390/toxins4121427

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free